SpaceX Stock Falls Below IPO Price as Investors Weigh Losses and Lockup Expiry 
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI 
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth 
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
UBS Boosts China Tech Bets, Adds Kuaishou and Meituan to Focus List 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features 
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report 
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
xAI Sues Man for Allegedly Using Grok to Generate AI Child Abuse Deepfakes 
BHP Q4 Iron Ore Output Rebounds as Copper Prices Boost Revenue 
Jamie Dimon Warns Anthropic's Mythos AI Poses National Security Risks 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
NEW YORK, Jan. 20, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of ERBA Diagnostics, Inc. (“ERBA”) (NYSEMKT:ERB) between April 14, 2014 and November 20, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Florida. If you purchased or otherwise acquired ERBA securities between April 14, 2014 and November 20, 2015, your rights may be affected by this action.To get more information go to:
http://zlk.9nl.com/erba-diagnostics
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that, throughout the Class Period, Defendants issued materially false and misleading statements and/or failed to disclose that: (1) ERBA’s accounting of intercompany transactions among its subsidiaries, including its consolidated financial statements, were improper and had an impact on reported assets and liabilities; (2) ERBA lacked adequate controls over financial reporting; (3) ERBA’s financial statements during the Class Period were materially false and misleading; and (4) as a result, Defendants’ statements about ERBA’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in ERBA you have until February 1, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
